CONMED Corporation
US ˙ NYSE ˙ US2074101013

SecurityCNMD / CONMED Corporation
InstitutionDimensional Fund Advisors Lp
Latest Disclosed Ownership1,284,761 shares
Ownership 4.53%
Dimensional Fund Advisors Lp ownership in CNMD / CONMED Corporation

2020-02-12 - Dimensional Fund Advisors Lp has filed an SC 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 1,284,761 shares of CONMED Corporation (US:CNMD). This represents 4.53 percent ownership of the company. In their previous filing dated 2019-02-08 , Dimensional Fund Advisors Lp had reported owning 1,640,062 shares, indicating a decrease of -21.66 percent.

Institutional Ownership: 13D/G Filings

This table shows a history of the 13D/G filings made by the investor and/or investor group. Note that the share values in this table are not directly comparable to any numbers shown in the 13F table (if any).

File
Date
Effective
Date
Form Prev
Shares
Latest
Shares
ΔShares
(Percent)
Ownership
(Percent)
ΔOwnership
(Percent)
2020-02-12 2020-02-12 13G/A 1,640,062 1,284,761 -21.66 4.53 -22.30
2019-02-08 2019-02-08 13G/A 2,147,161 1,640,062 -23.62 5.83 -24.19
2018-02-09 2018-02-09 13G/A 2,348,741 2,147,161 -8.58 7.69 -8.89
2017-02-09 2017-02-09 13G/A 2,335,120 2,348,741 0.58 8.44 0.12
2016-02-09 2016-02-09 13G/A 2,335,120 8.43
2015-02-05 2015-02-05 13G/A 2,323,731 8.44
2014-02-10 2014-02-10 13G/A 2,418,335 8.76
2013-02-11 2013-02-11 13G/A 2,399,016 8.42
2012-02-14 2012-02-14 13G/A 2,405,589 8.62

Important Note: One of the primary uses of the 13D/G filings is to evaluate the ability of a firm to control a company (ie, the "beneficial ownership"). To that end, firms are required to report not just direct holdings in companies, but indirect holdings that they control. For investment firms, these indirect holdings can include shares in funds they manage, advisory accounts, and in the case of activist campaigns, pledged votes. Therefore, share counts listed in 13D/G filings can differ significantly than share counts listed in 13F filings.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-07 2026-03-31 13F CONMED COM 207410101 1,392,920 80,116 6.10 49,250 -7.60 0.0022
2026-02-12 2025-12-31 13F CONMED COM 207410101 1,312,804 16,028 1.24 53,301 -12.60 0.0112
2025-11-12 2025-09-30 13F CONMED COM 207410101 1,296,776 214,126 19.78 60,984 8.16 0.0131
2025-08-12 2025-06-30 13F CONMED COM 207410101 1,082,650 184,211 20.50 56,385 3.93 0.0131
2025-05-13 2025-03-31 13F CONMED COM 207410101 898,439 122,999 15.86 54,253 2.23 0.0135
2025-02-13 2024-12-31 13F CONMED COM 207410101 775,440 57,149 7.96 53,073 2.73 0.0127
2024-11-07 2024-09-30 13F CONMED COM 207410101 718,291 -12,089 -1.66 51,664 2.05 0.0125
2024-08-09 2024-06-30 13F CONMED COM 207410101 730,380 -40,602 -5.27 50,628 -18.00 0.0132
2024-05-10 2024-03-31 13F CONMED COM 207410101 770,982 58,650 8.23 61,740 -20.86 0.0167
2024-02-07 2023-12-31 13F CONMED COM 207410101 712,332 33,794 4.98 78,010 14.00 0.0228
2023-11-09 2023-09-30 13F CONMED COM 207410101 678,538 5,218 0.77 68,432 -25.21 0.0224
2023-08-09 2023-06-30 13F CONMED COM 207410101 673,320 19,710 3.02 91,499 34.79 0.0292
2023-05-12 2023-03-31 13F CONMED COM 207410101 653,610 14,292 2.24 67,883 121,119.64 0.0229
2023-02-09 2022-12-31 13F CONMED COM 207410101 639,318 -1,252 -0.20 57 -99.89 0.0167
2022-11-10 2022-09-30 13F CONMED COM 207410101 640,570 20,956 3.38 51,356 -13.45 0.0197
2022-08-12 2022-06-30 13F CONMED COM 207410101 619,614 -26,348 -4.08 59,336 -38.17 0.0213
2022-05-13 2022-03-31 13F CONMED COM 207410101 645,962 -45,455 -6.57 95,959 -2.10 0.0296
2022-02-09 2021-12-31 13F CONMED COM 207410101 691,417 -64,764 -8.56 98,017 -0.93 0.0296
2021-11-12 2021-09-30 13F CONMED COM 207410101 756,181 -5,860 -0.77 98,933 -5.53 0.0319
2021-08-12 2021-06-30 13F CONMED COM 207410101 762,041 -46,207 -5.72 104,727 -0.78 0.0332
2021-05-14 2021-03-31 13F CONMED COM 207410101 808,248 -155,483 -16.13 105,549 -2.21 0.0349
2021-03-08 2020-12-31 13F/A-2 CONMED COM 207410101 963,731 -55,584 -5.45 107,938 34.61 0.0390
2021-02-11 2020-12-31 13F CONMED COM 207410101 963,731 -55,584 107,938 38,981.4684
2020-11-12 2020-09-30 13F CONMED COM 207410101 1,019,315 -57,375 -5.33 80,187 3.46 0.0340
2020-08-13 2020-06-30 13F CONMED COM 207410101 1,076,690 -39,547 -3.54 77,508 21.25 0.0341
2020-05-14 2020-03-31 13F CONMED COM 207410101 1,116,237 -168,524 -13.12 63,924 -55.51 0.0333
2020-02-14 2019-12-31 13F CONMED COM 207410101 1,284,761 -76,193 -5.60 143,673 9.79 0.0524
2019-11-12 2019-09-30 13F CONMED COM 207410101 1,360,954 -16,954 -1.23 130,856 10.98 0.0508
2019-08-13 2019-06-30 13F CONMED COM 207410101 1,377,908 -118,251 -7.90 117,908 -5.26 0.0458
2019-08-12 2019-03-31 13F/A-2 CONMED COM 207410101 1,496,159 -143,903 -8.77 124,449 18.20 0.0496
2019-05-10 2019-03-31 13F CONMED COM 207410101 1,496,159 -143,903 124,449
2019-02-26 2018-12-31 13F/A-1 CONMED COM 207410101 1,640,062 -115,403 -6.57 105,291 -24.29 0.0477
2019-02-13 2018-12-31 13F CONMED COM 207410101 1,640,062 -115,403 105,291
2018-11-13 2018-09-30 13F CONMED COM 207410101 1,755,465 -128,752 -6.83 139,068 0.83 0.0529
2018-08-10 2018-06-30 13F CONMED COM 207410101 1,884,217 -189,934 -9.16 137,925 5.00 0.0550
2018-05-11 2018-03-31 13F CONMED COM 207410101 2,074,151 -73,010 -3.40 131,356 20.02 0.0547
2018-02-12 2017-12-31 13F CONMED COM 207410101 2,147,161 -82,130 -3.68 109,441 -6.44 0.0454
2017-11-13 2017-09-30 13F CONMED COM 207410101 2,229,291 -34,730 -1.53 116,971 1.42 0.0511
2017-08-11 2017-06-30 13F CONMED COM 207410101 2,264,021 -79,465 -3.39 115,329 10.81 0.0532
2017-05-12 2017-03-31 13F CONMED COM 207410101 2,343,486 -5,255 -0.22 104,074 0.32 0.0497
2017-02-09 2016-12-31 13F CONMED COM 207410101 2,348,741 -14,373 -0.61 103,744 9.59 0.0518
2016-11-10 2016-09-30 13F CONMED COM 207410101 2,363,114 12,494 0.53 94,666 -15.62 0.0512
2016-08-09 2016-06-30 13F CONMED COM 207410101 2,350,620 38,595 1.67 112,193 15.70 0.0646
2016-05-13 2016-03-31 13F CONMED COM 207410101 2,312,025 -23,095 -0.99 96,965 -5.73 0.0580
2016-02-10 2015-12-31 13F CONMED COM 207410101 2,335,120 20,204 0.87 102,862 -6.92 0.0641
2015-11-13 2015-09-30 13F CONMED COM 207410101 2,314,916 -29,961 -1.28 110,514 -19.12 0.0725
2015-08-14 2015-06-30 13F CONMED COM 207410101 2,344,877 6,569 0.28 136,636 15.73 0.0837
2015-05-14 2015-03-31 13F CONMED COM 207410101 2,338,308 14,577 0.63 118,061 13.00 0.0746
2015-02-06 2014-12-31 13F CONMED COM 207410101 2,323,731 -26,468 -1.13 104,475 20.66 0.0686
2014-11-13 2014-09-30 13F CONMED COM 207410101 2,350,199 -30,727 -1.29 86,583 -17.63 0.0613
2014-08-08 2014-06-30 13F CONMED COM 207410101 2,380,926 25,859 1.10 105,117 2.73 0.0731
2014-05-14 2014-03-31 13F CONMED COM 207410101 2,355,067 -63,268 -2.62 102,327 -0.44 0.0765
2014-02-12 2013-12-31 13F CONMED COM 207410101 2,418,335 41,949 1.77 102,779 27.25 0.0801
2013-11-13 2013-09-30 13F CONMED COM 207410101 2,376,386 -15,403 -0.64 80,772 8.10 0.0699
2013-08-15 2013-06-30 13F CONMED COM 207410101 2,391,789 2,391,789 74,719 0.0704
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.